Chinese genetic testing co Suzhou Basecare rises in Hong Kong debut

Suzhou Basecare Medical

08/02/2021 02:35

** Shares of Chinese genetic testing company Suzhou Basecare
Medical Co Ltd  2170.HK  trade as high as HK$32.25 in Hong Kong
trading debut, up 17.9% from its IPO price
    ** Stock last up 1.6% from the issue price of HK$27.36
apiece; the eighth-most actively traded by turnover in early
trade  
    ** The Jiangsu-based co sold 66.7 mln shares at HK$27.36
each in Hong Kong IPO, raising HK$1.84 bln ($237.3 mln) for
clinical trial, commercialization of products, and to develop
R&D capabilities  urn:newsml:reuters.com:*:nFWN2K111O
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
gains 0.5%
    ** The Hang Seng China enterprises index  .HSCE  climbs 0.5%
and the benchmark index  .HSI  rises 0.7%
    ($1 = 7.7527 Hong Kong dollars)

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)